The Alpha VZN narrative
From siloed assumptions to a unified clinical-financial operating picture.
High-stakes healthcare decisions rarely fail because teams lack effort. They fail because
market intelligence, clinical outcomes data, supply chain economics, and reimbursement
assumptions live in separate systems — and the people making capital, contracting, and
service line decisions never see them in one view.
01
Build the clinical-economic case before first contact.
For MedTech and device companies, Alpha VZN translates facility-level claims data, DRG mix,
and payer reimbursement profiles into a buyer-ready financial narrative — so your sales team
walks in with the economic story the CFO and VAC already need to hear.
02
Quantify total cost of ownership before the VAC vote.
Value analysis committees can pressure-test new technology against operating margin impact,
OR utilization, case volume throughput, perioperative labor costs, and readmission risk —
all mapped to the service lines that matter most.
03
Benchmark chargemaster variance before renegotiation.
Contracting and supply chain teams get CPT-level pricing benchmarks, GPO tier analytics,
and historical contract performance context — so renewal conversations start from
evidence, not guesswork.
04
Model service line P&L before the capital request.
Hospital leaders can scenario-plan new program launches with integrated volume forecasts,
payer mix modeling, FTE ramp schedules, equipment depreciation, and contribution margin
projections — giving the board a decision-ready pro forma.
05
Walk into payor negotiations with the data they don't expect you to have.
Hospital contracts and managed care teams can leverage facility-level reimbursement
benchmarks, regional rate comparisons, and case mix acuity data to build an
evidence-based position before sitting down with commercial insurers and Medicare
Advantage plans — turning rate negotiations from a concession exercise into a
data-driven conversation where the health system sets the terms.